Thursday, January 23, 2020
Breaking Medical Device Industry News
Home RenalytixAI


    U.S. CPT® Code Granted for KidneyIntelX™

    A payment rate for the new code will be established for Medicare patients through the 2019 Clinical Lab Fee Schedule Annual Public Meeting process.

    Study Published in Journal of Clinical Investigation Insight Demonstrates Ability to Predict Early Rejection in Kidney Transplant with FractalDx Portfolio Technology

    Today RenalytixAI announced that positive study results have been published in the Journal of Clinical Investigation (JCI) Insight1.  These results show FractalDx portfolio technology...

    RenalytixAI Expands Core Investigator Group for Kidney Transplant Advanced Diagnostic Program

    As previously announced, RenalytixAI formed the FractalDx investigator group as part of its commercial program for advanced diagnostic tests expected to make significant improvements in the identification and monitoring for kidney transplant rejection, and to aid in accurate dosing of immune-suppression therapy.